1. Home
  2. CXM vs NNNN Comparison

CXM vs NNNN Comparison

Compare CXM & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.48

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$9.39

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXM
NNNN
Founded
2009
2021
Country
United States
Germany
Employees
N/A
27
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CXM
NNNN
Price
$5.48
$9.39
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$8.28
N/A
AVG Volume (30 Days)
3.7M
44.9K
Earning Date
06-03-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$857,200,000.00
N/A
Revenue This Year
$2.52
N/A
Revenue Next Year
$4.94
N/A
P/E Ratio
$275.00
$446.57
Revenue Growth
7.64
N/A
52 Week Low
$4.72
$10.50
52 Week High
$9.40
$55.65

Technical Indicators

Market Signals
Indicator
CXM
NNNN
Relative Strength Index (RSI) 58.79 23.86
Support Level $5.14 N/A
Resistance Level $5.60 $30.21
Average True Range (ATR) 0.19 2.12
MACD 0.05 -0.00
Stochastic Oscillator 82.21 17.53

Price Performance

Historical Comparison
CXM
NNNN

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: